This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $4,642.20, is for the delivery of Xolair 150 mg/ml syringes. The award has no set-aside designation and is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. This IDC enables the DLA to issue delivery orders for a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the medical supply needs of military health facilities worldwide. DMS Pharmaceutical Group's position as a key supplier in the federal pharmaceutical supply chain allows the company to provide direct distribution of prescription drugs and pharmacy services to Department of Defense healthcare sites.
Generated 3/6/25, 9:44 AM